Study of CYYR1 mRNA in Neuroendocrine Tumors
Author Information
Author(s): Vitale Lorenza, Frabetti Flavia, Huntsman Shane A, Canaider Silvia, Casadei Raffaella, Lenzi Luca, Facchin Federica, Carinci Paolo, Zannotti Maria, Coppola Domenico, Strippoli Pierluigi
Primary Institution: Department of Histology, Embryology and Applied Biology, University of Bologna, Bologna, Italy
Hypothesis
The study aims to analyze the sequence, splicing, and expression of the CYYR1 mRNA in human neuroendocrine tumors.
Conclusion
A new splicing isoform of CYYR1 mRNA was identified, and its expression levels were comparable in tumor samples and normal tissues.
Supporting Evidence
- The CYYR1 CDS did not show differences compared to the reference sequence in any of the samples, except for one NE tumor.
- NE tumor samples showed no significant difference in either CYYR1 CAG- or CAG+ isoform expression compared to control tissues.
- The CYYR1 CAG- isoform was significantly more expressed than the CAG+ isoform in both NE tumors and control samples.
Takeaway
Researchers looked at a gene called CYYR1 in tumors and found a new version of it that might work differently, but it was expressed similarly in both tumors and normal tissues.
Methodology
The CYYR1 mRNA coding sequence was studied in 32 neuroendocrine tumors using RT-PCR and sequence analysis.
Limitations
The study did not find significant differences in CYYR1 isoform expression between tumor and control tissues.
Participant Demographics
16 males and 11 females aged 43 to 79 years, mean age 63.6 years.
Statistical Information
P-Value
0.022
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website